Showing 5331-5340 of 8687 results for "".
- AAD Launches Campaign to Support Skin Self Examshttps://practicaldermatology.com/news/aad-launches-campaign-to-support-skin-self-exams/2457782/In recognition of Skin Cancer Awareness Month in May and Melanoma Monday® on May 7, the American Academy of Dermatology is encouraging the public to be a “Skin Can
- Bath Emollients Don't Add Much to Standard Eczema Carehttps://practicaldermatology.com/news/bath-emollients-dont-add-much-to-standard-eczema-care/2457784/Emollient bath additives provide no meaningful benefit when used in addition to standard eczema care in children, according to research in the BMJ. UK researchers, led by Miriam Santer, MBBChir
- FDA Agrees to Priority Review of Cemiplimab for Advanced Squamous Cell Carcinomahttps://practicaldermatology.com/news/fda-agrees-to-priority-review-of-cemiplimab-for-advanced-squamous-cell-carcinoma/2457785/The FDA has accepted the Biologics License Application (BLA) for cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC w
- Encore Dermatology Launches Impoyz Cream 0.025%, a Newly Formulated High-Potency Topical Corticosteroidhttps://practicaldermatology.com/news/encore-dermatology-launches-impoyz-cream-0025-a-newly-formulated-high-potency-topical-corticosteroid/2457787/Encore Dermatology Inc. launched its new topical product, Impoyz Cream, indicated for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older. Impoyz Cream is the only FDA-approved high-potency topical corticosteroid with 0.025% clobetasol propionate. &ld
- Acne Survey at Twins Convention Affirms Genetic Linkhttps://practicaldermatology.com/news/acne-survey-at-twins-convention-affirms-genetic-link/2457789/A survey of identical and fraternal twin pairs at the Twins Days Festival in Twinsburg, OH, and published in the April issue of the Journal of Drugs in Dermatology, shows acne may be primarily caused by genetics.
- Hair Products for Black Women May Contain Mix of Hazardous Ingredientshttps://practicaldermatology.com/news/hair-products-for-black-women-may-contain-mix-of-hazardous-ingredients/2457790/Black women are potentially exposed to dozens of hazardous chemicals through their hair products, finds a new report in the journal Environmental Research. The study, led by scientists at Silent Spr
- Cellulite Market Expected to Growhttps://practicaldermatology.com/news/cellulite-market-expected-to-grow/2457792/The cellulite treatment market is expected to grow worldwide, as the obesity epidemic grows. Findings are in the comprehensive research report by Future Market Insights entitled “Cellulite Treatment Market
- Saudi Arabia Welcomes Scalisi Skin Carehttps://practicaldermatology.com/news/saudi-arabia-welcomes-scalisi-skin-care/2457799/Select doctors’ offices and medical clinics across Saudi Arabia now carry the Scalisi collection. This adds to their existing distribution in spas and medispas in the US, Wynn and Encore Resorts in both Las Vegas, and Macau, China, and online on QVC.com, Amazon.com, and
- Study: Derms More Likely than PAs to Catch Early Skin Cancerhttps://practicaldermatology.com/news/study-derms-more-likely-than-pas-to-catch-early-skin-cancer/2457800/Physician assistants may be more likely than dermatologists to perform unnecessary skin biopsies to check for cancer and are less likely to accurately diagnose early stage skin cancers, according to new research conducted by the University of Pittsbur
- Most Indoor Tanners Aren't Getting Screened for Skin Cancerhttps://practicaldermatology.com/news/most-indoor-tanners-arent-getting-screened-for-skin-cancer/2457801/Most indoor tanners are not getting checked for skin cancer, a new study shows. Researchers analyzed data from the National Health Interview Survey of more than 30,000 U.S. adults. They looked at rates of s